Please wait while we open this resource.
K
Clinical reviews
CIRRHOSIS, PORTAL HYPERTENSION AND HEPATOCELLULAR CARCINOMA: A STAGE-BASED APPROACH
Manon Allaire, Tamar Taddei, Dominique Thabut, Guadalupe Garcia-Tsao
PDF202313 pages3.4 MB
Cirrhosis and hepatocellular carcinoma (HCC) are significant outcomes of chronic liver disease, with portal hypertension influencing both conditions. Current guidelines treat these issues separately, leading to inadequate risk stratification and treatment selection. This review advocates for an integrated, stage-based management approach that considers clinically significant portal hypertension as a critical factor in treatment decisions. It highlights the need for future research to validate non-invasive assessments of portal hypertension in HCC management.
Sign in to open
Ask this resource
Answers use this document only.
Your first question is free.
More like this
Resources from the same specialty and type. Curated links will replace these when added.
Clinical Resources
Documents that extend or complement this resource.
Hepatitis E Virus, Second Edition (Springer, 2023)
Same clinical topic · Hepatology
AUTOIMMUNE HEPATITIS
Same clinical topic · Hepatology
MOLECULAR MECHANISMS AND PATHOGENESIS OF MASH
Same clinical topic · Hepatology
NEW APPROACHES TO CHRONIC HEPATITIS B
Same clinical topic · Hepatology
CURRENT THERAPEUTIC LANDSCAPE AND FUTURE TREATMENT PERSPECTIVES OF MASH
Same clinical topic · Hepatology
RANDOMIZED, CONTROLLED CLINICAL TRIAL OF THE DIALIVE LIVER DIALYSIS DEVICE VERSUS STANDARD OF CARE IN PATIENTS WITH ACUTE ON-CHRONIC LIVER FAILURE
Same clinical topic · Hepatology
Intravenous albumin after outpatient paracentesis reduces the risk of AKI hospitalization: A national cohort study
Same clinical topic · Hepatology
LIVER TRANSPLANTATION FOR PATIENTS WITH SEVERE ACUTE ON CHRONIC LIVER FAILURE: IT IS TIME TO CHANGE PARADIGMS
Same clinical topic · Hepatology
HEPATITIS B
Same clinical topic · Hepatology